Business Description
Zenith Capital Corp
NAICS : 541714
SIC : 3741
ISIN : CA98935N1033
Share Class Description:
ZHCLF: Ordinary SharesDescription
Zenith Capital Corp is a biotechnology investment company. The company operates through its wholly-owned subsidiary Zenith Epigenetics Ltd. It is a clinical-stage biotechnology company focused on discovering and developing novel therapeutics. The company is developing various novel combinations of BET inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for metastatic Castration Resistant Prostate Cancer (mCRPC) in collaboration with Astellas and Newsoara and in metastatic triple-negative breast cancer.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.89 | |||||
9-Day RSI | 30.55 | |||||
14-Day RSI | 34.94 | |||||
6-1 Month Momentum % | 9.09 | |||||
12-1 Month Momentum % | -14.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -1.54 | |||||
EV-to-EBITDA | -1.59 | |||||
Earnings Yield (Greenblatt) % | -64.94 | |||||
FCF Yield % | -33.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ZHCLF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Zenith Capital Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.05 | ||
Beta | 0.15 | ||
Volatility % | 117.12 | ||
14-Day RSI | 34.94 | ||
14-Day ATR ($) | 0.015914 | ||
20-Day SMA ($) | 0.10465 | ||
12-1 Month Momentum % | -14.29 | ||
52-Week Range ($) | 0.01 - 0.25 | ||
Shares Outstanding (Mil) | 143.66 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zenith Capital Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zenith Capital Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Zenith Capital Corp Frequently Asked Questions
What is Zenith Capital Corp(ZHCLF)'s stock price today?
The current price of ZHCLF is $0.07. The 52 week high of ZHCLF is $0.25 and 52 week low is $0.01.
When is next earnings date of Zenith Capital Corp(ZHCLF)?
The next earnings date of Zenith Capital Corp(ZHCLF) is .
Does Zenith Capital Corp(ZHCLF) pay dividends? If so, how much?
Zenith Capital Corp(ZHCLF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |